A citation-based method for searching scientific literature

T A Zesiewicz, P E Greenstein, K L Sullivan, L Wecker, A Miller, I Jahan, R Chen, S L Perlman. Neurology 2012
Times Cited: 68







List of co-cited articles
847 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
G Ristori, S Romano, A Visconti, S Cannoni, M Spadaro, M Frontali, F E Pontieri, N Vanacore, M Salvetti. Neurology 2010
101
45

Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
941
32

A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease.
Jonas Alex Morales Saute, Raphael Machado de Castilhos, Thais Lampert Monte, Artur Francisco Schumacher-Schuh, Karina Carvalho Donis, Rui D'Ávila, Gabriele Nunes Souza, Aline Dutra Russo, Gabriel Vasata Furtado, Tailise Conte Gheno,[...]. Mov Disord 2014
46
43

Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial.
Silvia Romano, Giulia Coarelli, Christian Marcotulli, Luca Leonardi, Francesca Piccolo, Maria Spadaro, Marina Frontali, Michela Ferraldeschi, Maria Chiara Vulpiani, Federica Ponzelli,[...]. Lancet Neurol 2015
100
29

Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.
Ichiro Miyai, Mizuki Ito, Noriaki Hattori, Masahito Mihara, Megumi Hatakenaka, Hajime Yagura, Gen Sobue, Masatoyo Nishizawa. Neurorehabil Neural Repair 2012
94
26

Intensive coordinative training improves motor performance in degenerative cerebellar disease.
W Ilg, M Synofzik, D Brötz, S Burkard, M A Giese, L Schöls. Neurology 2009
143
25


Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases.
K Wessel, K Langenberger, M F Nitschke, D Kömpf. Arch Neurol 1997
21
61

A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.
M Strupp, R Kalla, J Claassen, C Adrion, U Mansmann, T Klopstock, T Freilinger, H Neugebauer, R Spiegel, M Dichgans,[...]. Neurology 2011
112
19

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.
Ludger Schöls, Peter Bauer, Thorsten Schmidt, Thorsten Schulte, Olaf Riess. Lancet Neurol 2004
657
19

Safety and efficacy of valproic acid treatment in SCA3/MJD patients.
Li-Fang Lei, Guo-Ping Yang, Jun-Ling Wang, De-Maw Chuang, Wei-Hong Song, Bei-Sha Tang, Hong Jiang. Parkinsonism Relat Disord 2016
34
38

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
17

Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease.
T Schulte, R Mattern, K Berger, S Szymanski, P Klotz, P H Kraus, H Przuntek, L Schöls. Arch Neurol 2001
31
35


The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
H Jacobi, P Bauer, P Giunti, R Labrum, M G Sweeney, P Charles, A Dürr, C Marelli, C Globas, C Linnemann,[...]. Neurology 2011
121
14

Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial.
Luis Velázquez-Pérez, Jorge Rodríguez-Chanfrau, Julio Cesar García-Rodríguez, Gilberto Sánchez-Cruz, Raúl Aguilera-Rodríguez, Roberto Rodríguez-Labrada, Julio Cesar Rodríguez-Díaz, Nalia Canales-Ochoa, Dennis Almaguer Gotay, Luis E Almaguer Mederos,[...]. Neurochem Res 2011
21
47

Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.
M I Botez, T Botez-Marquard, R Elie, O L Pedraza, K Goyette, R Lalonde. J Neurol Neurosurg Psychiatry 1996
61
16

Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
Nicholas A Di Prospero, Angela Baker, Neal Jeffries, Kenneth H Fischbeck. Lancet Neurol 2007
189
13

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
890
13

Responsiveness of different rating instruments in spinocerebellar ataxia patients.
T Schmitz-Hübsch, R Fimmers, M Rakowicz, R Rola, E Zdzienicka, R Fancellu, C Mariotti, C Linnemann, L Schöls, D Timmann,[...]. Neurology 2010
92
13

Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry.
I Yabe, H Sasaki, I Yamashita, A Takei, K Tashiro. Acta Neurol Scand 2001
45
20

Treatment of spinocerebellar ataxia with buspirone.
Mitra Assadi, Joseph V Campellone, Christopher G Janson, J Jon Veloski, Robert J Schwartzman, Paola Leone. J Neurol Sci 2007
20
45

Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.
L Wecker, M E Engberg, R M Philpot, C S Lambert, C W Kang, J C Antilla, P C Bickford, C E Hudson, T A Zesiewicz, Peter P Rowell. Neuropharmacology 2013
27
33

Consensus paper: management of degenerative cerebellar disorders.
W Ilg, A J Bastian, S Boesch, R G Burciu, P Celnik, J Claaßen, K Feil, R Kalla, I Miyai, W Nachbauer,[...]. Cerebellum 2014
88
13

The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Luis Ruano, Claudia Melo, M Carolina Silva, Paula Coutinho. Neuroepidemiology 2014
263
13



SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.
T Schmitz-Hübsch, P Giunti, D A Stephenson, C Globas, L Baliko, F Saccà, C Mariotti, M Rakowicz, S Szymanski, J Infante,[...]. Neurology 2008
81
11

4-aminopyridine and cerebellar gait: a retrospective case series.
Roman Schniepp, Max Wuehr, Maximilian Neuhaeusser, Ann Kathrin Benecke, Christine Adrion, Thomas Brandt, Michael Strupp, Klaus Jahn. J Neurol 2012
41
19

A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
David R Lynch, Susan L Perlman, Thomas Meier. Arch Neurol 2010
122
11

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
T Schmitz-Hübsch, M Coudert, P Bauer, P Giunti, C Globas, L Baliko, A Filla, C Mariotti, M Rakowicz, P Charles,[...]. Neurology 2008
168
11

The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia.
Taiji Tsunemi, Kinya Ishikawa, Kei Tsukui, Takuro Sumi, Ken Kitamura, Hidehiro Mizusawa. J Neurol Sci 2010
20
40


Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease: an open-label study.
Asako Takei, Toshiyuki Fukazawa, Takeshi Hamada, Hiroyuki Sohma, Ichiro Yabe, Hidenao Sasaki, Kunio Tashiro. Clin Neuropharmacol 2004
24
33

Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.
Andreia Teixeira-Castro, Ana Jalles, Sofia Esteves, Soosung Kang, Liliana da Silva Santos, Anabela Silva-Fernandes, Mário F Neto, Renée M Brielmann, Carlos Bessa, Sara Duarte-Silva,[...]. Brain 2015
50
16

Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study.
T L Monte, C R M Rieder, A B Tort, I Rockenback, M L Pereira, I Silveira, A Ferro, J Sequeiros, L B Jardim. Acta Neurol Scand 2003
25
32

A randomized pilot study of stochastic vibration therapy in spinocerebellar ataxia.
O Kaut, H Jacobi, C Coch, A Prochnicki, M Minnerop, T Klockgether, U Wüllner. Cerebellum 2014
18
44

Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/ataxia syndrome.
T A Zesiewicz, K L Sullivan, A Freeman, J L Juncos. Acta Neurol Scand 2009
18
38

Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Kathrin Reetz, Ana S Costa, Shahram Mirzazade, Anna Lehmann, Agnes Juzek, Maria Rakowicz, Romana Boguslawska, Ludger Schöls, Christoph Linnemann, Caterina Mariotti,[...]. Brain 2013
86
10

A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3.
Barbara S Connolly, L K Prashanth, Binit B Shah, Connie Marras, Anthony E Lang. Neurology 2012
8
87

The effectiveness of allied health care in patients with ataxia: a systematic review.
Ella M R Fonteyn, Samyra H J Keus, Carla C P Verstappen, Ludger Schöls, Imelda J M de Groot, Bart P C van de Warrenburg. J Neurol 2014
32
21

Long-term effects of coordinative training in degenerative cerebellar disease.
Winfried Ilg, Doris Brötz, Susanne Burkard, Martin A Giese, Ludger Schöls, Matthis Synofzik. Mov Disord 2010
77
10

Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration.
Y Shiga, T Tsuda, Y Itoyama, H Shimizu, K-I Miyazawa, K Jin, T Yamazaki. J Neurol Neurosurg Psychiatry 2002
51
13

Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series.
Michael Strupp, Julian Teufel, Maximilian Habs, Regina Feuerecker, Carolin Muth, Bart P van de Warrenburg, Thomas Klopstock, Katharina Feil. J Neurol 2013
49
14

Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial.
Javier Arpa, Irene Sanz-Gallego, Josmarlin Medina-Báez, Luis Valmor Cruz Portela, Laura Bannach Jardim, Ignacio Torres-Aleman, Jonas Alex Morales Saute. Mov Disord 2011
24
29

Effectiveness and safety of treatments for degenerative ataxias: a systematic review.
M Mar Trujillo-Martín, Pedro Serrano-Aguilar, Fernando Monton-Alvarez, Romen Carrillo-Fumero. Mov Disord 2009
40
17

Difference in the effects of tandospirone on ataxia in various types of spinocerebellar degeneration: an open-label study.
Asako Takei, Shinsuke Hamada, Sanae Homma, Keiko Hamada, Kunio Tashiro, Takeshi Hamada. Cerebellum 2010
15
46

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Heike Jacobi, Sophie Tezenas du Montcel, Peter Bauer, Paola Giunti, Arron Cook, Robyn Labrum, Michael H Parkinson, Alexandra Durr, Alexis Brice, Perrine Charles,[...]. Lancet Neurol 2015
116
10

Occupational therapy in spinocerebellar ataxia type 3: an open-label trial.
R C R Silva, J A M Saute, A C F Silva, A C O Coutinho, M L Saraiva-Pereira, L B Jardim. Braz J Med Biol Res 2010
22
31

Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix).
Theresa A Zesiewicz, Kelly L Sullivan, Clifton L Gooch, David R Lynch. J Clin Neuromuscul Dis 2009
13
46


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.